Landos Biopharma Inc. March 25, 2024 - by Joey Ramson $LABP, a biopharmaceutical company focused on the development of first-in-class, oral therapeutics for patients with autoimmune diseases is being acquired by AbbVie ($ABBV). Share this article:
